Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP plus adipose-derived stem cells for periorbital dark circles
IRCT20200127046282N49Phase 2Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jul 2024
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of platelet-rich plasma and adipose derived mesenchymal stromal cells in infraorbital hyperchromia, sponsored by Tehran University of Medical Sciences. Primary endpoints: Safety and tolerability of PRP + adipose-derived stem cells and Improvement in periorbital dark circles. Started Jul 2024; status: completed.
02
Drugs
platelet-rich plasmaadipose derived mesenchymal stromal cells
03
Conditions
infraorbital hyperchromia
Beyond the preview
Go deeper on IRCT20200127046282N49.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200127046282N49.